FDA, NIH & Industry Advance Templates for Clinical Trial Protocols
By Michael Mezher -
Published 03 May 2017
The US Food and Drug Administration (FDA) and National Institutes of Health (NIH) on Tuesday released the final version of a common template for clinical trial protocols intended to save sponsors of NIH-funded Phase II and III studies both time and money.
Tags: Common protocol template, CPT, TransCelerate BioPharma